EWTX earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -23.09. Updated 2026-07-23.
Edgewise Therapeutics (EWTX) Research Hub
Edgewise Therapeutics (EWTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 44.4 USD (+2.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -23.09, market cap 4.17B. This hub links to the full technical, earnings and options research available for EWTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 44.4 USD (+2.33%) |
| 52-week range | 33.72 USD – 48.4 USD |
| Trend regime | Range |
| 14-day RSI | 53.3 (Neutral) |
| Trailing P/E | -23.09 |
| Market cap | 4.17B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for EWTX
Covered Call on EWTX: how it works, illustrative setup around the real 44.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EWTX: how it works, illustrative setup around the real 44.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EWTX: how it works, illustrative setup around the real 44.4 USD price, max profit/loss, breakeven and when to use it. Educational.
EWTX technical analysis: range, last 44.4 USD, RSI 53.3, 52w range 33.72 USD–48.4 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is EWTX in?
Edgewise Therapeutics (EWTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is EWTX in an uptrend or downtrend?
As of 2026-09-11, EWTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EWTX's trailing P/E ratio?
EWTX's trailing P/E is -23.09, with a market cap of 4.17B. See the earnings research page for full valuation detail.
When does EWTX next report earnings?
EWTX is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.48 USD.